Que Pharma
Que Pharma is an Indian privately-held pharmaceutical manufacturer, founded 1981 in Gujarat, producing generic formulations across 11 therapeutic categories and offering contract manufacturing services for domestic and export markets in CIS, Asia, and Africa.
- Company typePrivate
- Founded1981
- HeadquartersSurendranagar, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Que Pharma does
Que Pharma Pvt. Ltd. is an Indian pharmaceutical manufacturer founded in 1981 and headquartered in Surendranagar, Gujarat, operating a 38,000 sq ft WHO-GMP, ISO 9001:2008, and Schedule M certified production facility. The company develops and manufactures generic formulations across eleven therapeutic categories, with particular emphasis on antiallergic and antifungal products, and has built specialized capability in oral drug delivery formats including fast-release tablets and mouth-dissolving formulations such as Onda-Q MD. Its product portfolio is sold under proprietary brands, and the firm also offers contract manufacturing and third-party/loan-license (CMO/CDMO) production services to other pharmaceutical companies.
The company is led by three founders/promoters — Jaykant H. Sanghvi, Dilip D. Mair, and Rajendra H. Sanghvi — each with 35-43 years of industry experience. Que Pharma distributes its finished formulations in India through a field force and stockist network, and exports via local marketing partners to CIS countries, Asia, and Africa. The firm is privately held, has 11-50 employees, has not raised external funding, and has no public M&A history; its most recent strategic moves consist of two product launches (Racimol Tablets and Onda-Q MD) in November 2019, a website launch in April 2018, and ongoing maintenance of regulatory certifications for its single manufacturing site.
Que Pharma firmographics
Firmographics- Name
- Que Pharma
- Legal name
- Que Pharma Pvt. Ltd.
- Website
- https://quepharma.com
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Que Pharma is an Indian privately-held pharmaceutical manufacturer, founded 1981 in Gujarat, producing generic formulations across 11 therapeutic categories and offering contract manufacturing services for domestic and export markets in CIS, Asia, and Africa.
- Ownership category
- akta.pro rank
Que Pharma industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)
- akta.pro secondary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
Keywords
Where Que Pharma is headquartered
LocationHeadquarters
- HQ city
- Surendranagar
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Que Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Product Manufacturing and Sales: Manufacturing and marketing of branded and generic pharmaceutical formulations including tablets, capsules, oral liquids, ointments. Revenue generated from sale of proprietary pharmaceutical products across various therapeutic categories.
- Contract Manufacturing Services: Providing world-class contract manufacturing services to pharmaceutical companies worldwide. Services include purchasing of raw materials, production, packaging and quality control. Operating as a CMO/CDMO in India.
- Loan Licence Manufacturing: Pharmaceutical contract manufacturing under loan license arrangements for third-party pharmaceutical companies.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Que Pharma product offering
Product offeringCore offering
Que Pharma develops, manufactures, and markets branded and generic pharmaceutical formulations across 11 therapeutic categories including antiallergic, antibiotics, antifungal, analgesic/antipyretic, anthelmintic, antacid, anti-malarial, dermatology, gastroenterology, NSAIDs, and vitamins/supplements. The company also provides end-to-end pharmaceutical contract manufacturing services (CMO/CDMO) for domestic and international pharmaceutical companies, covering raw material procurement, production, packaging, and quality control at its 38,000 sq. ft. WHO-GMP certified facility in Surendranagar, Gujarat.
Product overview
Que Pharma is a GMP Certified pharmaceutical manufacturing company established in 1981, offering a comprehensive portfolio of branded and generic pharmaceutical formulations across 11 therapeutic categories: Antiallergic (CET-Q, CETQ-L, CETQ-LM, FEXEN products), Antibiotics (AZIQ, CEFA-Q, GERMICEF, LINQ, Q-CEF, Q-LIF, Q-MOX, QUIX, Q-VID products), Antifungal (LULIBAN, MYTRA, PHYTRA, Q-CAN, TINEAFIN, ULTRAKET products), Analgesic/Antipyretic & Anticold (DECOLD, HISTA products), Anthelmintic (Q-ANZOL products), Antacid/Alkliser (Q-CITRA), Anti Malarial (QUINTHER-LF), Dermatology (AD-Q-PLUS, DERMAC-GM, FILMOIST, NOURIHAIR, ROSACLIN products), Gastroenterology (MYFATE-O, OMI-Q, PENTAQ, RABIQ products), NSAID/Pain Management (ACQ, DF-PLUS, MEF, NIQ, RACIMOL products), and Vitamins/Supplements (BIOTIQ, FERRY-XT, FOLIB, FOXGARD, VITAFEROL products). The company also offers oral drug delivery innovation technologies including customized controlled-release drug delivery, bioavailability enhancement, taste masking, fast release tablets, melt-in-mouth tablets, and smaller sized solid orals. Contract manufacturing services are provided through flexible arrangements including raw material purchasing, production, packaging and quality control. QUE stands for Quality, Utility, and Efficiency/Economy.
Differentiator
Problem solved
Functional benefit
Products and services
- Contract Manufacturing Alliance
- Loan Licence Manufacturing
- Antiallergic Product Range (CET-Q, CETQ-L, CETQ-LM, FEXEN 120/180, FEXEN-M)
- Antibiotic Product Range (AZIQ, CEFA-Q, GERMICEF, LINQ, Q-CEF, Q-LIF, Q-MOX, QUIX, Q-VID)
- Antifungal Product Range (LULIBAN, MYTRA, PHYTRA, Q-CAN, TINEAFIN, ULTRAKET)
- Analgesic / Antipyretic & Anticold Product Range (DECOLD, HISTA)
- Anthelmintic Product Range (Q-ANZOL)
- Antacid/Alkliser Product Range (Q-CITRA)
- Anti-Malarial Product Range (QUINTHER-LF)
- Dermatology Product Range (AD-Q-PLUS, DERMAC-GM, FILMOIST, NOURIHAIR, Q-CAN KZ, Q-SCAB, RAYBEAT, ROSACLIN, SUPRABET, SUPRAMOM)
- Gastroenterology Product Range (MYFATE-O, OMI-Q, ONDAQ-MD, PENTAQ, PENTA-Q, RABIQ)
- NSAID / Pain Management Product Range (ACQ, DF-PLUS, MEF, NIQ, RACIMOL, VERIMEF)
Quantifiable outcome
- >75% dissolution rate within first 5 mins at all pH range for Racimol fast release Paracetamol
- +1 more outcomes
Companies that use Que Pharma
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Que Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Que Pharma partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- Companies in Asian CountriesminorTie-ups with companies having presence in Asian countries for distribution and marketing of pharmaceutical products. Strategic partnerships enable market reach in these regions through local expertise and distribution networks.
- Companies in African CountriesminorPartnerships with pharmaceutical companies in African countries for product distribution. Relationships established to serve the African pharmaceutical market with quality products.
- Companies in CIS (Commonwealth of Independent States) CountriescoreExtensive experience of working with clients in CIS countries. Que Pharma has the technical infrastructure and expertise required to develop healthcare and pharmaceutical products complying with the norms of CIS countries. Strategic partnerships for product supply and regulatory compliance.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
Que Pharma competitors and assessment
Company assessmentDirect peers
- FDC Limited: Indian pharmaceutical company focused on branded generic formulations across anti-infective, gastrointestinal, ophthalmic, and nutrition categories with strong domestic field force. Comparable to Que Pharma in India-domestic branded generics focus and similar mid-market positioning.
- Wanbury: Indian pharma manufacturer with API and finished dosage form operations across similar therapeutic categories, serving domestic and emerging markets. Comparable to Que Pharma in manufacturing-focused generics model and emerging-market reach.
- Marksans Pharma: Indian generic pharmaceutical company with manufacturing for global markets including regulated and emerging geographies (US, Europe, Australia). Comparable to Que Pharma in generics-led portfolio with international distribution focus, though larger in scale.
- Vivimed Labs: Small-to-mid Indian specialty pharmaceutical manufacturer with branded generics and contract manufacturing operations across multiple therapeutic areas. Closely comparable to Que Pharma in scale, India-centric footprint, and combination of own-brand plus CMO business.
- Indoco Remedies: Indian pharmaceutical manufacturer offering formulations across anti-infective, antiallergic, NSAID, and other therapeutic categories with both domestic branded generics and contract manufacturing. Highly comparable to Que Pharma in product mix, manufacturing model, and Indian mid-market positioning.
- Hikal: Indian CDMO offering contract development and manufacturing services across pharmaceuticals and specialty chemicals with GMP-certified facilities. Directly comparable to Que Pharma's CDMO/loan-license contract manufacturing business line.
Broad incumbents
- Unichem Laboratories: Established Indian pharmaceutical company with branded and generic formulations, API manufacturing, and international presence. Larger than Que Pharma but operates in overlapping therapeutic categories and similar CMO-style partnerships for emerging markets.
- Recipharm: Global pharmaceutical CDMO providing contract development and manufacturing services across oral solids and other dosage forms. Comparable to Que Pharma's CMO/CDMO service line but operating globally at much larger scale.
- Aurobindo Pharma: One of India's largest generic pharmaceutical manufacturers with extensive API and formulation operations, significant contract manufacturing, and global reach. Overlaps with Que Pharma in generic formulations and CMO activities but at vastly greater scale.
- Ipca Laboratories: Vertically integrated Indian pharmaceutical manufacturer with strong presence in anti-malarial, anti-infective, and pain management categories — directly overlapping with Que Pharma's therapeutic mix. Larger scale and global API/formulation footprint.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Que Pharma social profiles
Digital presenceQue Pharma compliance and trust
Trust signalCompliance4 records
Que Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Que Pharma leadership team
Management profileNumber of profiles
Profiles3 records
Que Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Que Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Que Pharma
What does Que Pharma do?
Que Pharma develops, manufactures, and markets branded and generic pharmaceutical formulations across 11 therapeutic categories including antiallergic, antibiotics, antifungal, analgesic/antipyretic, anthelmintic, antacid, anti-malarial, dermatology, gastroenterology, NSAIDs, and vitamins/supplements. The company also provides end-to-end pharmaceutical contract manufacturing services (CMO/CDMO) for domestic and international pharmaceutical companies, covering raw material procurement, production, packaging, and quality control at its 38,000 sq. ft. WHO-GMP certified facility in Surendranagar, Gujarat.
Is Que Pharma a public or private company?
Que Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Que Pharma founded?
Que Pharma was founded in 1981. It employs 11 to 50 people.
Where is Que Pharma based?
Que Pharma is headquartered in Surendranagar, India, in the Asia region.
How does Que Pharma make money?
Three revenue lines are on record. Pharmaceutical Product Manufacturing and Sales are the primary driver. The others are contract Manufacturing Services and loan Licence Manufacturing.
Who are Que Pharma's main competitors?
Direct peers on record are FDC Limited, Wanbury, Marksans Pharma, Vivimed Labs, Indoco Remedies and Hikal. Broad incumbents are Unichem Laboratories, Recipharm, Aurobindo Pharma and Ipca Laboratories.
Does Que Pharma have an API?
No public API is recorded for Que Pharma.
What industry is Que Pharma in?
Que Pharma's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO), with a secondary code of HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO. Its NAICS code is 3254 and its SIC code is 2834.